The company’s revenue increased by 19.4% to $700 million in the first nine months of 2012, thus, helping Gexin’s net worth surge by 11% to $123 million. Planning to expand its product line and sales network, Kelun announced in December 2013 to purchase up to 30% of Hong Kong-listed Lijun International Pharmaceutical for up to $316 million. As the company’s deputy general manager serves Lui’s brother Liu Suihua.